Ariad's (ARIA -4.5%) slides on reports that a growing number of tools are allowing many cancer patients to skip chemotherapy or other cancer treatments. Also, ongoing trials of its experimental cancer drug AP26113 has only clouded the picture regarding its potential. A smaller proportion of patients saw their tumors shrink than shown in a previous release and it's unclear whether 2 patient deaths were caused by the drug or something else. Analysts expect more clarity when ARIApresents more-mature data at June's ASCO cancer meeting. [View news story]
Sure, why not blame the "death prone" patient on the drug trying to save their life?. I am not giving up on this company. I have pushed tougher drugs than this that made it well. Ex Pharma rep.
What Does The Gold/Silver Ratio Tell Us Now? [View article]
I always thought GLD and SLV followed the price of real Gold and Silver, Duh! and so at the historic 16:1 ratio either Silver must rise to $50 an ounce or Gold falls to $800 for this ratio. I'm betting by summer 2013 that Gold (real metal) will be close to $800-900 and Silver close to $40-45. Let's see.
Gold (GLD) futures jumped nearly $40/oz. to log their biggest one-day gain of the year, supported by physical demand, prospects for easier global monetary policies and a weaker U.S. dollar. Today's rally brings gold's recovery to ~50% of losses from the selloff that began ~$1,560. Silver (SLV) enjoyed an even bigger bounce, rising 5.7%, but it needs a lot of catching up to approach historical gold/silver ratios. [View news story]
I'm looking for Gold to fall to $700-800 level this summer. Silver to catch up to 16:1 ratio. That would be $50. Where are the HUNT Brothers when you need them?
ServiceNow: Analysts Say Buy But Insiders Rush To Sell Big [View article]
Isn't it terrible that investors are actually scared to get into the market? It used to be that people were willing to buy a little share or two or ten and they would watch it go up up up. Now, the market has been so crazy the last five years, I'm actually waiting for the market to dip deep again.
So I'm watching on the sidelines. Waiting for a large dip and improving economy. Don't get me started on politics...
Why Are Investors Excited About Ariad? [View article]
I trust Goldman and Sacs about as much as I trust any shyster on the street. Remember they- Goldman - Cramer's pet company - were involved heavily in the Obama let's print millions and the Housing bust, etc. We Americans have an itty bitty memory. It sounds like a great company. I would rather have the chance for bleeding ulcers than die by not taking the drug. Look at your aspirin and Tylenol fine print. That's scarey, too. Just saying.
I am still very excited about the drug and since I used to be a drug rep back in the 70s I know about the negative crap that's printed. I sold a #1 drug in its class and it had horrible reviews at first. I went to the ER last month and got some generic med on my visit. The silver bullet has yet to be found. Buy ARIA.
Precious metals go into the tank on chatter the G-7 is set to issue a statement in which all will pledge to get along with regards to currency devaluation. The G-20 meets in Moscow at week's end. GLD -1.2%, SLV -1.5%. [View news story]
I'm with Tampat, another buying opportunity coming. Ask China and India to stop buying Gold and I'll listen, maybe.
Gold slipping in the wake of the Fed's even easier policies doesn't surprise Uri Landesman, who sees a dramatic correction ahead. The metal performs best as a "flight to quality," he argues, and the Fed moves take that bid away. His downside target next year is $1,400/oz. [View news story]
BernAnke and the Gold fake out means nothing to the entire world like Brazil, China etc. Gold will win out and GLD will follow real gold sooner or later because they buy gold like you do.
The Up-Tick Rule Reimplementation Is Bad for Markets [View article]
Hahahaha
I had no idea this column was a comic's column. So, the author likes not having the uptick rule. Really? Funnnnnnneeeee. Thanks for giving all some comic relief from the current market conditions.
Ariad's (ARIA -4.5%) slides on reports that a growing number of tools are allowing many cancer patients to skip chemotherapy or other cancer treatments. Also, ongoing trials of its experimental cancer drug AP26113 has only clouded the picture regarding its potential. A smaller proportion of patients saw their tumors shrink than shown in a previous release and it's unclear whether 2 patient deaths were caused by the drug or something else. Analysts expect more clarity when ARIA presents more-mature data at June's ASCO cancer meeting. [View news story]
What Does The Gold/Silver Ratio Tell Us Now? [View article]
Gold (GLD) futures jumped nearly $40/oz. to log their biggest one-day gain of the year, supported by physical demand, prospects for easier global monetary policies and a weaker U.S. dollar. Today's rally brings gold's recovery to ~50% of losses from the selloff that began ~$1,560. Silver (SLV) enjoyed an even bigger bounce, rising 5.7%, but it needs a lot of catching up to approach historical gold/silver ratios. [View news story]
Ariad Pharmaceuticals' CEO Hosts Investor Conference (Transcript) [View article]
ServiceNow: Analysts Say Buy But Insiders Rush To Sell Big [View article]
It used to be that people were willing to buy a little share or two or ten and they would watch it go up up up. Now, the market has been so crazy the last five years, I'm actually waiting for the market to dip deep again.
So I'm watching on the sidelines. Waiting for a large dip and improving economy. Don't get me started on politics...
Why Are Investors Excited About Ariad? [View article]
I am still very excited about the drug and since I used to be a drug rep back in the 70s I know about the negative crap that's printed. I sold a #1 drug in its class and it had horrible reviews at first. I went to the ER last month and got some generic med on my visit. The silver bullet has yet to be found. Buy ARIA.
Precious metals go into the tank on chatter the G-7 is set to issue a statement in which all will pledge to get along with regards to currency devaluation. The G-20 meets in Moscow at week's end. GLD -1.2%, SLV -1.5%. [View news story]
Gold slipping in the wake of the Fed's even easier policies doesn't surprise Uri Landesman, who sees a dramatic correction ahead. The metal performs best as a "flight to quality," he argues, and the Fed moves take that bid away. His downside target next year is $1,400/oz. [View news story]
The Good And Bad Of Investing In Chipotle [View article]
Ark Restaurants: A Low Risk Value Play, Part II [View article]
Wall Street Breakfast: Must-Know News [View article]
Wall Street Breakfast: Must-Know News [View article]
Cramer's Lightning Round - Keen on Celgene (4/24/09) [View article]
The Up-Tick Rule Reimplementation Is Bad for Markets [View article]
I had no idea this column was a comic's column. So, the author likes not having the uptick rule. Really? Funnnnnnneeeee. Thanks for giving all some comic relief from the current market conditions.
Cramer's Lightning Round - Only Wal-Mart (1/29/09) [View article]